Form 4: Director Gallagher's Health Catalyst RSU Vesting
Insider Transaction Report
Health Catalyst Director Duncan Gallagher reported the vesting of 7,562 restricted stock units on February 17, 2026.
Summary
- Duncan Gallagher, a Director at Health Catalyst, Inc. (HCAT), reported the acquisition of 7,562 shares of common stock.
- This transaction represents the vesting of restricted stock units (RSUs) granted under the company's 2019 Stock Option and Incentive Plan.
- The RSUs vested 100% on February 17, 2026, with a transaction price of $0.00 per share.
- Following this transaction, Duncan Gallagher beneficially owns 132,023 shares of Health Catalyst common stock.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting a routine compensation action that increases director ownership, aligning interests without indicating new operational performance.
Positives
- The vesting of restricted stock units for Director Duncan Gallagher indicates continued alignment of management interests with shareholder value.
- An increase in a director's direct ownership through vesting can be viewed as a positive signal regarding their long-term commitment to the company.
Industry Context
StockSavvy.ai notes that equity awards and their vesting are standard components of executive and director compensation packages across the healthcare technology industry, designed to align leadership incentives with long-term company performance.
Stakeholder Impact
- Shareholders: Increased director ownership may signal confidence, potentially viewed positively.
Key Dates
| Date | Description |
|---|---|
| 02/17/2026 | Date of transaction where 7,562 restricted stock units vested. |
| 02/19/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine vesting of restricted stock units for a director, which is an expected compensation event and does not provide new information to warrant a change in investment recommendation. It reinforces director alignment but offers no new insights into the company's operational or financial performance.
Keywords
Health Catalyst, HCAT, Duncan Gallagher, Form 4, Restricted Stock Units, RSU Vesting, Insider Transaction, Director Compensation, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.